Evan Susandi
Overview
Explore the profile of Evan Susandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harti G, Maulida S, Susandi E, Fadjari T, Sumardi U, Alisjahbana B, et al.
J Blood Med
. 2025 Feb;
16:61-74.
PMID: 39926111
Purpose: This study aimed to compare platelet count, platelet indices, lymphocyte, and systemic inflammation indices between surviving and non-surviving COVID-19 patients, measured at admission and on the eighth day of...
2.
Mardia A, Hamijoyo L, Susandi E, Prihatni D, Alisjahbana B, Oehadian A
Int J Rheum Dis
. 2024 Dec;
27(12):e15449.
PMID: 39655457
Objectives: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by the presence of autoantibodies against nuclear antigens and immune complex deposition. The pathogenesis of SLE is not fully...
3.
Hamijoyo L, Philo P, Nathan D, Tiara M, Mardiana S, Susandi E, et al.
Clin Exp Vaccine Res
. 2024 Nov;
13(4):348-358.
PMID: 39525676
Purpose: We aim to analyze the proportion and level of coronavirus disease 2019 (COVID-19) seropositivity in patients with systemic lupus erythematosus (SLE) and explore factors associated with lower anti-severe acute...
4.
Hartantri Y, Andriyoko B, Debora J, Rachman F, Susandi E, Ferdian F, et al.
IJID Reg
. 2024 Jun;
11:100379.
PMID: 38855022
Objectives: We aimed to compare the clinical severity and outcome among laboratory-confirmed Omicron variant cases admitted between January and December 2022. Methods: This is a cross-sectional study conducted in Hasan...
5.
Andhika R, Anand M, Tiara M, Debora J, Djauhari H, Susandi E, et al.
Vaccines (Basel)
. 2023 Dec;
11(12).
PMID: 38140206
Patients with end-stage kidney disease on hemodialysis (ESKD-HD) have a high risk of contracting severe COVID-19. Vaccination can help reduce disease severity, but the immune dysregulation observed in these patients...
6.
Hataul I, Soetedjo N, Debora J, Tiara M, Djauhari H, Susandi E, et al.
Vaccines (Basel)
. 2023 Sep;
11(9).
PMID: 37766101
Type 2 diabetes mellitus (T2DM) is associated with higher severity and mortality in SARS-CoV-2 infections. Vaccination has been encouraged to boost immunity and prevent these unfortunate outcomes. Few studies have...
7.
Muslimah A, Tiara M, Djauhari H, Dewantara M, Susandi E, Indrati A, et al.
Vaccines (Basel)
. 2023 Aug;
11(8).
PMID: 37631868
In August 2022, Indonesia prioritized healthcare workers to receive the second booster dose. We conducted a sequential serosurvey to understand the dynamics of the antibody titers. The first serosurvey, which...
8.
Kusumawati M, Koesoemadinata R, Fatma Z, Susandi E, Permana H, Mulyani Soetedjo N, et al.
PLoS One
. 2023 Jun;
18(6):e0286797.
PMID: 37319126
Immune system dysregulation in people with diabetes mellitus (DM) increases the risk of acquiring severe infection. We compared the clinical characteristics and laboratory parameters of coronavirus disease 2019 (COVID-19) patients...
9.
Hartantri Y, Debora J, Widyatmoko L, Giwangkancana G, Suryadinata H, Susandi E, et al.
Lancet Reg Health Southeast Asia
. 2023 Feb;
11:100167.
PMID: 36785545
Background: Indonesia had the second-highest number of COVID-19 cases and deaths in South-East Asia. We aimed to determine the factors associated with this mortality and the effect of the recommended...
10.
Hamijoyo L, Sahiratmadja E, Ghassani N, Darmawan G, Susandi E, van Crevel R, et al.
Open Forum Infect Dis
. 2022 Jul;
9(7):ofac201.
PMID: 35794932
Background: In previous studies, researchers have identified systemic lupus erythematosus (SLE) as a risk factor for tuberculosis (TB), but data from TB-endemic countries are still relatively scarce. We examined TB...